Featured

Altria: Trump’s Cannabis Pivot May Trigger An Investor Gold Rush

Summary Altria comprises over 20% of my dividend stock portfolio, and I am optimistic about its... Read more »

Qureator Names Dr. Branka Mitrovic as Chief Scientific Officer

Qureator, a leading AI-powered human disease model company, today announced the appointment of Dr. Branka Mitrovic as... Read more »

Q&A with Jordan Watson, CEO of Alsana

Jordan Watson serves as Alsana’s Chief Executive Officer, bringing nearly 15 years of experience in the eating... Read more »

citybiz
Gain exposure through our multi-channel news platform.

Q&A with Ben Plomion, Chief Operating Officer of Pearl

Inogen Appoints Mira Kirti Sahney to Board of Directors

Fore Genomics Partners with Inocras

2025’s States With the Best & Worst Dental Health – WalletHub Study

Tyra Biosciences Appoints Adele Gulfo to Board of Directors

RiverVest Venture Partners Join $97 Series B For Atalanta Therapeutics

Anivive Secures $20 Million Investment from Leonid Capital Partners

Dr. Susan Cotter of Marshall B. Ketchum University Earns Global Recognition for Transformative Contributions to Optometry

Alsana Launches Virtual Eating Disorder Treatment Program for Adolescents in California

Kailera Therapeutics Appoints Jamie Coleman as Chief Commercial Officer

Andrew Ratz, Ph.D., Appointed Senior Vice President of Drug Development at Neurocrine Biosciences

Planet DDS and Pearl Redefine Dental Care Standards with AI Assist

Neomorph Appoints Dr. Klaus Wagner as Chief Medical Officer

David P. King Appointed to Truvian Advisory Board

Light Horse Therapeutics Raises $62M in Series A

RyboDyn Raises $4M in Funding